Source: Health Canada shortage reports · Updated Aug 24, 2026
A shortage of Capecitabine is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A chemotherapy medication used to treat cancers such as breast and colorectal cancer.
Products affected
0 / 14
Reports on file
53
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
CAPECITABINE
150MG · TABLET · SANIS HEALTH INC
DIN 02514982 · Disruption of the manufacture of the drug.
Resolved
CAPECITABINE
500MG · TABLET · JAMP PHARMA CORPORATION
DIN 02519887 · ended Aug 6, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421925 · ended Jan 8, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Dec 18, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Dec 16, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Nov 5, 2025 · Disruption of the manufacture of the drug.
Resolved
CAPECITABINE
150MG · TABLET · SANIS HEALTH INC
DIN 02514982 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Resolved
CAPECITABINE
500MG · TABLET · SANIS HEALTH INC
DIN 02514990 · ended Sep 3, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Jul 24, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
500MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457504 · ended Jun 4, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CAPECITABINE
150MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02457490 · ended Apr 16, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ CAPECITABINE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02421925 · ended Feb 17, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 53 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Capecitabine to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Capecitabine is classified under “ANTIMETABOLITES” (ATC L01BC).
Recent changes
Aug 24, 2026
New report filed
Aug 7, 2026
Shortage resolved
Jul 29, 2026
Estimated end date pushed back : Jun 26, 2026 → Jul 31, 2026
Common questions
What is Capecitabine used for?
A chemotherapy medication used to treat cancers such as breast and colorectal cancer.
When will Capecitabine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Capecitabine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.